Koyfin Home > Directory > Health Care > Amphastar Pharma > Gross Profit

Amphastar Pharma Gross Profit Chart (AMPH)

Amphastar Pharma annual/quarterly Gross Profit from 2014 to 2018. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Amphastar Pharma Gross Profit for the quarter ending December 12, 2018 was $35m a 50.60% increase of 18m year over year
  • Amphastar Pharma Gross Profit for the last 12 months ending December 12, 2018 was $107m a 20.45% increase of 22m year over year
  • Amphastar Pharma Annual Gross Profit for 2018 was $107m a 15.13% increase of 16m from 2017
  • Amphastar Pharma Annual Gross Profit for 2017 was $91m a -14.75% decrease of -13m from 2016
  • Amphastar Pharma Annual Gross Profit for 2016 was $104m a 25.76% increase of 27m from 2015
Other Income Statement Metrics:
  • Amphastar Pharma EBITDA for the quarter ending December 12, 2018 was $6m a 196.48% increase of 11m year over year
  • Amphastar Pharma Net Income for the quarter ending December 12, 2018 was $2m a 488.11% increase of 9m year over year
  • Amphastar Pharma Total Revenue for the quarter ending December 12, 2018 was $90m a 34.89% increase of 31m year over year
View Chart On Koyfin

Quarterly AMPH Gross Profit Data

12/2018$35m
09/2018$29m
06/2018$26m
03/2018$17m
12/2017$21m
09/2017$21m
06/2017$27m
03/2017$23m
12/2016$20m
09/2016$28m

Annual AMPH Gross Profit Data

2018$107m
2017$91m
2016$104m
2015$77m
2014$51m
2013$87m